Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:24 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 748 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Preterm Labor, Premature Birth Clear all

Conditions: Infant, Newborn, Diseases, Other Preterm Infants, Infant, Small for Gestational Age, Premature Birth, Bronchopulmonary Dysplasia, Retinopathy of Prematurity
Interventions: Surfactant, Continuous Positive Airway Pressure (CPAP), Supplemental oxygen with target saturation of 85 to 89%, Supplemental oxygen with target saturation of 91 to 95%; Drug · Device
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: 24 Weeks to 27 Weeks
Enrollment: 1,316 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2016
U.S. locations: 22
States / cities: Birmingham, Alabama • Palo Alto, California • San Diego, California + 18 more

Conditions: Preterm Birth
Interventions: Not listed
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Maternal Depressive Disorder Complicating Childbirth, Preterm Birth, Maternal Anxiety Disorder Complicating Childbirth
Interventions: Maternal voice; Other
Lead sponsor: AdventHealth; Other
Eligibility: Up to 3 Weeks
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Premature Birth, Preterm Birth
Interventions: PEA POD Infant Body Composition System; Device
Lead sponsor: Vishal Pandey, M.D.; Other
Eligibility: 23 Weeks to 42 Weeks
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Bronchopulmonary Dysplasia
Interventions: Azithromycin, Placebo; Drug
Lead sponsor: Hubert Ballard; Other
Eligibility: Up to 72 Hours
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2012
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Preterm Birth, Preterm Labor, Bacteremia, Preterm Premature Rupture of Fetal Membranes
Interventions: Prenatal vitamin-mineral containing 3 mg fluoride, Prenatal vitamin-mineral containing 0 mg fluoride; Drug · Dietary Supplement
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Preterm Birth
Interventions: Human milk fortifier; Dietary Supplement
Lead sponsor: Augusta University; Other
Eligibility: Up to 4 Days
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Preterm Infant, Cerebral Palsy
Interventions: Supporting Play Exploration and Developmental Intervention (SPEEDI); Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: Up to 6 Months
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 2
States / cities: Los Angeles, California • Richmond, Virginia

Conditions: Prematurity, Respiratory Insufficiency, Pulmonary Hypertension, Respiratory Distress Syndrome, Newborn
Interventions: Aerosolized Normal Saline, Inhaled PGE1; Drug
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 7 Days
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 11
States / cities: Birmingham, Alabama • Los Angeles, California • Palo Alto, California + 8 more

Conditions: Preeclampsia Severe, Pre-Eclampsia, Preeclampsia, Preeclampsia Second Trimester, Preeclampsia Complicating Childbirth, Preeclampsia Puerperium, Preterm
Interventions: Metformin, Esomeprazole; Drug
Lead sponsor: Christiana Care Health Services; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Preterm Infant, Early-Onset Neonatal Sepsis, Umbilical Cord
Interventions: Placental/Umbilical Cord Blood sample; Other
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: Up to 1 Day
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Bronchopulmonary Dysplasia (BPD)
Interventions: Benchmarking Management Practices, Standard Management Practices; Other
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 36 Weeks
Enrollment: 4,095 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2004
U.S. locations: 17
States / cities: Birmingham, Alabama • Palo Alto, California • San Diego, California + 13 more

Conditions: Premature Birth, Breastfeeding, Exclusive, Feeding; Difficult, Newborn
Interventions: taVNS soterix device; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 35 Weeks and older
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Chlamydia Trachomatis Infection, Neonatal Infection, Preterm Birth, Gonorrhea
Interventions: Chlamydia trachomatis and Neisseria gonorrhoeae screening using the GeneXpert; Other
Lead sponsor: University of Southern California; Other
Eligibility: 15 Years and older · Female only
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Nutrition Disorders, Gastrointestinal Disease, Deglutition Disorder, Feeding Difficulties, Swallowing Difficulties, Humans, Cohort Studies, Infant, Newborn, Infant, Premature, Nutrition, Pediatric Feeding Disorder, Chronic, Retrospective Studies, Breastfeeding, Mental Health Wellness, Intensive Care Units, Neonatal, Bottle Feeding
Interventions: SMART Tool for Feeding Skill Assessment; Diagnostic Test
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 22 Weeks to 42 Weeks
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Infant, Very Low Birth Weight
Interventions: Similac special care 30, Similac human milk fortifier; Dietary Supplement
Lead sponsor: University of Oklahoma; Other
Eligibility: 1 Day to 10 Weeks
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Premature Birth
Interventions: Arabin Pessary; Device
Lead sponsor: Gene Lee, MD; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 2
States / cities: Kansas City, Kansas • Charleston, South Carolina

Conditions: Prematurity
Interventions: DHA oil, (MCT) Control oil; Dietary Supplement
Lead sponsor: Sanford Health; Other
Eligibility: 24 Weeks to 33 Weeks
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Bronchopulmonary Dysplasia (BPD), Respiratory Distress Syndrome, Prematurity; Extreme, Neonatal
Interventions: budesonide (Pulmicort nebulizing suspension)., surfactant (poractant alfa;Curosurf); Drug
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 48 Hours
Enrollment: 642 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 19
States / cities: Birmingham, Alabama • Palo Alto, California • San Diego, California + 15 more

Conditions: Retinopathy of Prematurity, Retinal Detachment, Blindness
Interventions: ACULAR, REFRESH TEARS, placebo; Drug
Lead sponsor: University of South Alabama; Other
Eligibility: 10 Days to 15 Days
Enrollment: 83 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Mobile, Alabama

Conditions: Premature; Infant, Light-for-dates
Interventions: Protein supplementation, Standard fortification; Dietary Supplement
Lead sponsor: University of Oklahoma; Other
Eligibility: 1 Minute to 1 Year
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Enterocolitis, Necrotizing, Intestinal Perforation
Interventions: Laparotomy, Drainage; Procedure
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 8 Weeks
Enrollment: 529 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2019
U.S. locations: 22
States / cities: Birmingham, Alabama • Los Angeles, California • Palo Alto, California + 18 more

Conditions: Growth, Development, Infant
Interventions: infant formula, control infant formula; Other
Lead sponsor: Société des Produits Nestlé (SPN); Industry
Eligibility: Up to 1 Month
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 9
States / cities: Oakland, California • Park Ridge, Illinois • Iowa City, Iowa + 6 more

Conditions: Idiopathic Hyperbilirubinemia, Neonatal Hyperbilirubinemia, Prematurity
Interventions: Phototherapy, glycerin suppository; Procedure · Drug
Lead sponsor: University of Rochester; Other
Eligibility: 30 Weeks to 35 Weeks
Enrollment: 79 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Rochester, New York

Search by objective public record fields.

Surfactant Positive Airway Pressure and Pulse Oximetry Trial

Maternal Gut Microbiome (MGM) Study of Diet, the Gut Microbiome and Preterm Birth

Mother's Recorded Voice for Preterm Infants

Impact of Currently Recommended Postnatal Nutrition on Neonatal Body Composition

Trial II of Lung Protection With Azithromycin in the Preterm Infant

Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Being

Human Milk in Preterm Infants

Does Timing Matter? Supporting Play, Exploration, and Early Developmental Intervention

Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)

Metformin and Esomeprazole in Preterm Pre-eclampsia

Utility of Placental/Umbilical Cord Blood in Early Onset Neonatal Sepsis in Very Low Birth Weight Infants

Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia

taVNS-Paired Breastfeeding to Improve Breastfeeding at Discharge

Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences

Review of Infant Oral Feeding and Skills

Liquid Preterm Formula Versus Powdered Human Milk Fortifier in VLBW Infants

Cervical Pessary to Prevent Preterm Birth in Singleton Pregnancies With a Sonographically Measured Short Cervix

Bridging the Docosahexaenoic Acid (DHA) Gap: The Effects of Omega-3 Fatty Acid Supplementation in Premature Infants

The Budesonide in Babies (BiB) Trial

Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity

Effect of Protein Intake on Preterm Infant Body Composition

Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis

Preterm Infant Growth

Glycerin Suppositories to Reduce Jaundice in Premature Infants